Some Pharmacological And Phytochemical Studies Of Clitoria Ternatea Extracts
Loading...
Date
2012-01
Authors
Linggam, Kamilla
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
In this thesis, detailed work was carried out to explore and determine the
phytochemical screening, potential anti-infective, antioxidant and analgesic
properties of C. ternatea plant parts using various bioassays techniques and
appropriate experimental models. The initial qualitative phytochemical screening
shows that C. ternatea plant parts contain tannin, phlobatannin, flavonoid,
anthraquinone, alkaloid, saponin, cardiac glycosides, volatile oils, steroids and
terpenoids. The flavonoids and phenolic content of the various plant parts were also
determined in the plant parts. Analysis shows that C. ternatea flower extract has both
high phenolic (104.77 ± 2.64 mg GAE/g) and flavonoid (28.10 ± 4.13 mg CE/g)
content than other plant parts. This is evident by the fact that C. ternatea flower
extract exhibited the highest antioxidant activity (FRAP: 6.80 ± 0.32 μM Fe(II)/g ;
DPPH IC50 : 9.17 ± 0.003 μg/mL) when compared to other parts of the plant. One of
the bioactives identified in the flower extract was kaempferol-3-glucoside (K3G)
which is a flavonoid compound. Kaempferol-3-glucoside was also found in C.
ternatea stem and leaf. This could be one of the identified bioactives responsible for
the antioxidant activity. As for the in vitro anti-infective screening, both leaf and root
crude extracts demonstrated marked antimicrobial activities. Interestingly, the leaf
extract demonstrated a remarkable antifungal activity against Aspergillus niger with
a MIC and MFC of 0.4 and 0.8 mg/mL, respectively. This was evident by the
scanning electron microscope (SEM) analysis which showed a marked
morphological alteration of the A. niger hyphal wall and conidiophores after
exposure to C. ternatea leaf extract when compared to control. The acute toxicity of C. ternatea leaf extract was assessed in mice prior to antinociceptive and in vivo
antifungal study. After oral administration in mice, the LD50 was found to be higher
than 2000 mg/kg body weight which indicated some high level of safety for C.
ternatea leaf extract. Subsequently C. ternatea leaf extract was further tested for its
antinociceptive and in vivo antifungal activities in animal models. Studies in rats
showed that both C. ternatea leaf and root extracts demonstrated antinociceptive
activity at the studied dosage regimens when compared with control but the analgesic
effect was not comparable to morphine treated rats. In another study, the in vivo
antifungal activity of C. ternatea leaf extract was investigated in A. niger infected
mice. C. ternatea leaf extract antifungal activity was comparable to clinically used
amphotericin B. Bioactivity guided fractionation studies of the C. ternatea leaf
extract suggest that the antifungal activity could be a synergistic activity of various
bioactives presence in the extract. Further gas chromatography-mass spectroscopy
(GC-MS) and fourier transform infrared (FTIR) analysis of the fractions indicated
these bioactives could be lipids and/or terpenoids (sesquiterpenes) group of
compounds.
Description
Keywords
Centrosema